GFRα4 CAR T Cells in MTC Patients

GFRα4 CAR T Cells in MTC Patients
Condition:   Metastatic Medullary Thyroid Cancer
Interventions:   Drug: single dose of CART-GFRa4 cells;   Drug: Fludarabine;   Drug: Cyclophosphamide
Sponsor:   University of Pennsylvania

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 20, 2022Comments | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine